Increased Lipoprotein(a) levels are predictive of the presence, development, and progression of aortic stenosis, suggesting a causal association and potential target for specific lowering therapies.
What is the role of Lipoprotein(a) in the pathogenesis, development, and progression of aortic stenosis?
This review highlights the significant role of Lp(a) in the pathogenesis of aortic stenosis and underscores the need for research into Lp(a)-lowering therapies for prevention and treatment.
AIMS: The role of Lp(a) in cardiovascular diseases is increasingly recognized, with high Lp(a) levels shown to be associated with worse outcomes. In this review, we aim to summarize the literature and the current research status regarding AS and Lp(a) with a comprehensive approach, in order to inform basic and clinical scientists with the most up-to-date data and insights. DATA SYNTHESIS: Lp(a) is significantly involved in the pathogenesis of aortic stenosis (AS), with the interplay between AS and Lp(a) being documented in observational studies and a causal association being proposed based on genetic studies. Patients with AS have generally higher levels of Lp(a) and increased Lp(a) levels are associated with higher risk of AS development. The above observations offer opportunities for further research, mainly regarding potential therapeutic implications, particularly considering the Lp(a)-specific lowering therapies that are awaited to influence the prevention and treatment strategies for AS. CONCLUSION: Increased Lp(a) levels can be predictive of the presence, development and progression of AS, as well as could offer novel insights in the pathophysiology of bioprosthetic valve function. Further research, focusing on Lp(a)-lowering agents, is key in order to identify any benefit in such patient phenotypes.
Dimitriadis et al. (Wed,) conducted a review in Aortic stenosis. Lipoprotein(a) was evaluated. Increased Lipoprotein(a) levels are predictive of the presence, development, and progression of aortic stenosis, suggesting a causal association and potential target for specific lowering therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: